SCHEMBL4369765

SCHEMBL4369765

O=C(NC(=S)Nc1cccc(Oc2ccccc2)c1)c1cc2cc(Br)ccc2o1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.53
NPC1 O15118 6/20 0.53
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
TP53 P04637 1/20 0.51
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51
NLRP3 Q96P20 1/20 0.51
MAPT P10636 4/20 0.50
ALDH1A1 P00352 4/20 0.50
PPARG P37231 1/20 0.50
NCOA2 Q15596 1/20 0.50
NCOA1 Q15788 1/20 0.50
NCOA3 Q9Y6Q9 1/20 0.50
LMNA P02545 1/20 0.50
HPGD P15428 1/20 0.50
POLB P06746 2/20 0.49
BCAT1 P54687 1/20 0.47
F12 P00748 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4360387 0.89 NPC1 (0.67) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL4360435 0.89 KMT2A (0.57) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL14096096 0.88 MEN1 (0.53) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL4374032 0.87 MAPT (0.66) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL4366836 0.85 RAB9A (0.51) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL2862485 0.85 RAB9A (0.53) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL4366198 0.85 MAPT (0.53) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL3141249 0.84 RAB9A (0.56) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL2910241 0.83 ALDH1A1 (0.62) RAB9ANPC1KMT2AMEN1SMN1; SMN2
Hydrochloric Acid SCHEMBL2910327 0.82 ALDH1A1 (0.61) RAB9ANPC1KMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US claimed
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication CHEN DAWEI 2006-01-19 US claimed
US-20040138205-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. 2004-07-15 US claimed
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US disclosed
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US disclosed
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US disclosed
US-7094807-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2006-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138205-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication NAT1, PIGS, TPMT RAB9A 2176/4885NPC1 107/4885KMT2A 2216/4885
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication NAT1, PIGS, SLC10A1 RAB9A 2273/4885NPC1 151/4885KMT2A 1703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.